Orasure Technologies Share Price (NASDAQ: OSUR)

$3.31

▲

0.02

(0.61%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Orasure Technologies Stock chart to analyse performance

Orasure Technologies stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$3.29
Today's High:$3.35
$3.31
0.6%
Downside
Day's Volatility :1.79%
Upside
1.19%
52 Weeks Low:$2.36
52 Weeks High:$4.60
$3.31
28.7%
Downside
52 Weeks Volatility :48.7%
Upside
28.04%

Orasure Technologies Stock Returns

Period	Orasure Technologies Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	16.32%	3.6%	0.0%
6 Months	-7.14%	-7.7%	0.0%
1 Year	-24.14%	-12.6%	0.0%
3 Years	-16.71%	10.2%	-4.1%

Orasure Technologies Inc Key Stats

Check Orasure Technologies key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$3.29
Open	$3.33
Today's High	$3.35
Today's Low	$3.29
Market Capitalization	$242.1M
Today's Volume	$747.3K
52 Week High	$4.6
52 Week Low	$2.36
Revenue TTM	$138.5M
EBITDA	$-41.9M
Earnings Per Share (EPS)	$-0.68
Profit Margin	-36.84%
Quarterly Earnings Growth YOY	0.3%
Return On Equity TTM	-12.66%

Stock Returns calculator for Orasure Technologies Stock including INR - Dollar returns

The Orasure Technologies stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Orasure Technologies investment value today

Current value as on today

₹81,028

Returns

₹18,972

(-18.97%)

Returns from Orasure Technologies Stock

₹24,256 (-24.26%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Orasure Technologies Stock

-20%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Orasure Technologies Stock from India on INDmoney has decreased by -20% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Orasure Technologies Inc

Name
Holdings %
Name
Holdings %
BlackRock Inc
9.38%
Private Management Group Inc
6.04%
Neuberger Berman Group LLC
5.85%
Vanguard Group Inc
5.81%
Dimensional Fund Advisors, Inc.
5.25%
Acadian Asset Management LLC
3.77%

Analyst Recommendation on Orasure Technologies Stock

Rating

Trend

Buy

50%Buy

50%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Orasure Technologies(by analysts ranked 0 to 5 stars)

Orasure Technologies Share Price Target

What analysts predicted

Upside of 81.27%

Target:

$6.00

Current:

$3.31

Orasure Technologies share price target is $6.00, a slight Upside of 81.27% compared to current price of $3.31 as per analysts' prediction.

Orasure Technologies Stock Insights

Price Movement
In the last 7 days, OSUR stock has moved up by 10.5%
Decreasing Revenue
Revenue is down for the last 3 quarters, 37.44M → 31.24K (in $), with an average decrease of 97.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 5 quarters, -615.0K → -19.69M (in $), with an average decrease of 210.9% per quarter
OSUR vs RMD (1 yr)
In the last 1 year, Resmed Inc. has given 12.2% return, outperforming this stock by 38.2%
OSUR vs ISRG (3 yr)
In the last 3 years, Intuitive Surgical, Inc. has given 25.0% return, outperforming this stock by 43.9%
Price to Sales
ForOSUR every $1 of sales, investors are willing to pay $1.8, whereas for Resmed Inc., the investors are paying $7.8 for every $1 of sales.

Orasure Technologies Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$154.6M	↓ 14.93%
Net Income	$16.7M	↓ 18.34%
Net Profit Margin	10.77%	↓ 0.45%

	FY20	Y/Y Change
Revenue	$171.7M	↑ 11.07%
Net Income	$-14.9M	↓ 189.59%
Net Profit Margin	-8.69%	↓ 19.46%

	FY21	Y/Y Change
Revenue	$233.7M	↑ 36.08%
Net Income	$-23.0M	↑ 54.12%
Net Profit Margin	-9.84%	↓ 1.15%

	FY22	Y/Y Change
Revenue	$387.5M	↑ 65.82%
Net Income	$-17.9M	↓ 22.01%
Net Profit Margin	-4.63%	↑ 5.21%

	FY23	Y/Y Change
Revenue	$405.5M	↑ 4.64%
Net Income	$53.7M	↓ 399.16%
Net Profit Margin	13.23%	↑ 17.86%

	FY24	Y/Y Change
Revenue	$185.8M	↓ 54.17%
Net Income	$-19.5M	↓ 136.34%
Net Profit Margin	-10.49%	↓ 23.72%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$54.1M	↓ 28.66%
Net Income	$-3.6M	↓ 117.85%
Net Profit Margin	-6.62%	↓ 33.07%

	Q2 FY24	Q/Q Change
Revenue	$54.3M	↑ 0.38%
Net Income	$-615.0K	↓ 82.84%
Net Profit Margin	-1.13%	↑ 5.49%

	Q3 FY24	Q/Q Change
Revenue	$264.0K	↓ 99.51%
Net Income	$-4.5M	↑ 632.85%
Net Profit Margin	-1.7K%	↓ 1706.07%

	Q4 FY24	Q/Q Change
Revenue	$37.4M	↑ 14083.71%
Net Income	$-10.8M	↑ 139.49%
Net Profit Margin	-28.83%	↑ 1678.37%

	Q1 FY25	Q/Q Change
Revenue	$934.0K	↓ 97.51%
Net Income	$-16.0M	↑ 48.6%
Net Profit Margin	-1.7K%	↓ 1688.51%

	Q2 FY25	Q/Q Change
Revenue	$31.2K	↓ 96.66%
Net Income	$-19.7M	↑ 22.77%
Net Profit Margin	-63.0K%	↓ 61316.4%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$94.6M	↓ 16.75%

	FY20	Y/Y Change
Profit	$101.9M	↑ 7.7%

	FY21	Y/Y Change
Profit	$117.6M	↑ 15.44%

	FY22	Y/Y Change
Profit	$147.6M	↑ 25.54%

	FY23	Y/Y Change
Profit	$179.4M	↑ 21.53%

	FY24	Y/Y Change
Profit	$79.4M	↓ 55.75%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$24.3M	↓ 31.83%

	Q2 FY24	Q/Q Change
Profit	$25.6M	↑ 5.28%

	Q3 FY24	Q/Q Change
Profit	$17.1M	↓ 33.26%

	Q4 FY24	Q/Q Change
Profit	$13.8M	↓ 19.09%

	Q1 FY25	Q/Q Change
Profit	$12.3M	↓ 10.95%

	Q2 FY25	Q/Q Change
Profit	$13.2K	↓ 99.89%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$9.8M	↓ 74.92%
Investing Cash Flow	$-19.8M	↑ 13.6%
Financing Cash Flow	$-4.7M	↑ 147.59%

	FY20	Y/Y Change
Operating Cash Flow	$5.8M	↓ 40.77%
Investing Cash Flow	$-14.0M	↓ 29.14%
Financing Cash Flow	$92.5M	↓ 2075.2%

	FY21	Y/Y Change
Operating Cash Flow	$-35.4M	↓ 709.3%
Investing Cash Flow	$-5.5M	↓ 60.79%
Financing Cash Flow	$-2.8M	↓ 103.05%

	FY22	Y/Y Change
Operating Cash Flow	$-47.2M	↑ 33.41%
Investing Cash Flow	$21.1M	↓ 483.29%
Financing Cash Flow	$-3.8M	↑ 35.89%

	FY23	Y/Y Change
Operating Cash Flow	$141.6M	↓ 399.95%
Investing Cash Flow	$66.2M	↑ 213.75%
Financing Cash Flow	$-3.0M	↓ 21.03%

	FY24	Y/Y Change
Operating Cash Flow	$27.4M	↓ 80.67%
Investing Cash Flow	$-39.0M	↓ 158.99%
Financing Cash Flow	$-4.2M	↑ 38.14%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$6.7M	↓ 83.71%
Investing Cash Flow	$-46.5M	↓ 252.28%
Financing Cash Flow	$-1.3M	↑ 265.35%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$7.8M	↑ 16.4%
Investing Cash Flow	$5.7M	↓ 112.17%
Financing Cash Flow	$-2.0M	↑ 57.36%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$12.7M	↑ 61.68%
Investing Cash Flow	$7.3M	↑ 29.47%
Financing Cash Flow	$-727.0K	↓ 64.38%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$109.0K	↓ 99.14%
Investing Cash Flow	$-5.5M	↓ 174.92%
Financing Cash Flow	$-111.0K	↓ 84.73%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-19.7M	↓ 18203.67%
Investing Cash Flow	$370.0K	↓ 106.74%
Financing Cash Flow	$-953.0K	↑ 758.56%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-10.2M	↓ 48.19%
Investing Cash Flow	$-1.9M	↓ 623.24%
Financing Cash Flow	$-5.8M	↑ 508.39%

Orasure Technologies Technicals Summary

Sell

Neutral

Buy

Orasure Technologies is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Orasure Technologies Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Orasure Technologies Inc	10.13%	-7.14%	-24.14%	-16.71%	-69.73%
Intuitive Surgical, Inc.	-2.14%	-16.61%	-2.2%	129.39%	91.27%
Alcon Ag	-9.17%	-15.22%	-16.6%	20.12%	40.07%
West Pharmaceutical Services Inc	3.24%	8.32%	-18.78%	-16.58%	-12.33%
Resmed Inc.	-1.56%	17.91%	12.23%	25.22%	53.62%
Becton, Dickinson And Company	9.36%	-15.57%	-20.36%	-24.43%	-19.91%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Orasure Technologies Inc	26.67	NA	2.3	-0.63	-0.13	-0.07	NA	5.16
Intuitive Surgical, Inc.	66.27	66.27	3.47	8.14	0.16	0.09	NA	49.79
Alcon Ag	36.78	36.78	2.16	3.1	0.05	0.03	0.0	44.73
West Pharmaceutical Services Inc	36.74	36.74	3.55	6.76	0.18	0.11	0.0	40.74
Resmed Inc.	28.99	28.99	1.9	9.5	0.26	0.14	0.01	40.77
Becton, Dickinson And Company	35.34	35.34	0.96	14.37	0.06	0.04	0.02	88.87

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Orasure Technologies Inc	Buy	$242.1M	-69.73%	26.67	-36.84%
Intuitive Surgical, Inc.	Buy	$169.9B	91.27%	66.27	28.51%
Alcon Ag	Buy	$39.3B	40.07%	36.78	10.7%
West Pharmaceutical Services Inc	Buy	$17.7B	-12.33%	36.74	16.48%
Resmed Inc.	Buy	$40.3B	53.62%	28.99	27.22%
Becton, Dickinson And Company	Buy	$55.3B	-19.91%	35.34	7.41%

About Orasure Technologies Inc

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products, specimen collection devices, and other diagnostic products in the United States, Europe, Africa, and internationally. The company's products include OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, and OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; and Colli-Pee collection devices for the volumetric collection of void urine samples. In addition, the company provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; OMNIgene SALIVA DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Further, it offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. Additionally, the company develops a molecular self-test for chlamydia trachomatis and neisseria gonorrhoeae. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, nutrition, companion animal, and environmental markets. OraSure Technologies, Inc. was incorporated in 2000 and is h

Organization	Orasure Technologies
Employees	501
CEO	Ms. Carrie Eglinton Manner
Industry	Health Technology

Key Management of Orasure Technologies Inc

Name	Title
Ms. Carrie Eglinton Manner	President, CEO & Director
Mr. Kenneth J. McGrath	Chief Financial Officer
Ms. Michele Anthony	Senior VP, Chief Accounting Officer, Controller & Assistant Secretary
Ms. Karen Davies	Diagnostics R&D & Chief Technologist
Mr. Rafal Iwasiow Ph.D.	Sample Management Solutions R&D & Chief Scientist
Mr. Jason Michael Plagman	Vice President of Investor Relations
Mr. Stefano Taucer	General Counsel & Corporate Secretary
Mr. David A. Rappaport C.F.A.	Senior Vice President of Corporate Development, Strategy & Integration
Ms. Amy Steigerwalt	Senior Vice President of Human Resources
Mr. Zachary Wert	Senior Vice President of Global Operations

Important FAQs about investing in OSUR Stock from India :

What is Orasure Technologies share price today?

Orasure Technologies share price today is $3.31 as on August 30, 2025 at 1:29 am IST at the close of the market. Orasure Technologies share today touched a day high of $3.35 and a low of $3.29.

What is the 52 week high and 52 week low for Orasure Technologies share?

Orasure Technologies share touched a 52 week high of $4.60 and a 52 week low of $2.36. Orasure Technologies stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $3.31, lower by 28.04% versus the 52 week high.

How to invest in Orasure Technologies Stock (OSUR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Orasure Technologies on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Orasure Technologies Shares that will get you 0.4532 shares as per Orasure Technologies share price of $3.31 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Orasure Technologies Stock (OSUR) from India?

Indian investors can start investing in Orasure Technologies (OSUR) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Orasure Technologies stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Orasure Technologies share’s latest price of $3.31 as on August 30, 2025 at 1:29 am IST, you will get 3.0211 shares of Orasure Technologies. Learn more about fractional shares .

What are the returns that Orasure Technologies has given to Indian investors in the last 5 years?

Orasure Technologies stock has given -69.73% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?